Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelofibrosis
Related studies linked through entity extraction aliases.
Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA
INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical and Pathophysiological Investigations Into Erdheim Chester Disease
- Status
- COMPLETED
- Phase
- N/A
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)
- Status
- COMPLETED
- Phase
- PHASE1
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Anti-TGF-beta Therapy in Patients With Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE1
Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States
- Status
- COMPLETED
- Phase
- PHASE2
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2